Formulation design and evaluation of self-microemulsifying drug delivery system of sirolimus

Chinese Pharmaceutical Journal

Volumn 45, Issue 3, 2010, Pages 193-198

  Sun, Ming Hui ^a,c   Zhai, Xue Zhen ^b   Si, Lu Qin ^b   Li, Gao ^b   Yang, Xiang Liang ^c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c School of Life Science and Technohgy   (China)

Author keywords

Bioavailability; Microemulsion; Self microemulsifying drug delivery system; Sirolimus

Indexed keywords

RAPAMYCIN;

ARTICLE; CONCENTRATION RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MASS SPECTROMETRY; MICROEMULSION; NONHUMAN; PARTICLE SIZE; RAT; ULTRAVIOLET RADIATION;

EID: 77956493361     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. MURGIA M G, JORDAN S, KAHAN B D. The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients[J]. Kidney In, 1996,49(1):209-216.
2. KAHAN B D, CHANG J Y, SEHGAL S N. Preclinical evaluation of a new potent immunosuppressive agent, rapamycin[J]. Transplantation, 1991,52(2):185-191.
3. VIGNOT S, FAIVRE S, AGUIRRE D, et al. mTOR-targeted therapy of cancer with rapamycin derivatives[J]. Ann Oncol, 2005,16(4):525-537.
4. KAHAN B D. Update on pharmacokinetic/pharmacodynamic studies with FTY720 and sirolimus[J]. Ther Drug Monit, 2002,24(1):47-52.
5. GURSOY R N, BENITA S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs[J]. Biomed Pharmacother, 2004,58(3):173-182.
6. SUN M H, SI L Q, ZHAI X Z, et al. Determination of rapamycin in rat whole blood by HPLC-MS/MS[J]. Chin Pharm J, 2010,45(2):132-135.
7. HUGHERS P, MUSSER J, CONKLIN M. The isolation, synthesis and characterization of an isomeric form rapamycin[J]. Tetrahedron Lett, 1992,33(33):4739-4742.
8. YAO J L, WANG H J, XU Y, et al. Determination of rapamicin oral solution and its stability[J]. Clin J Pharm, 2006,37(11):765-767.
9. CHEN Y C, XIONG S B, XING H Y, et al. In vitro release of rapamycin sustained eluting stent detected by a new designed circulating device[J]. Chin Pharm J, 2008,43(5):688-692.
10. PORTER C J H, POUTON C W, CUINE J F, et al. Enhancing intestinal drug solubilisation using lipid-based delivery systems[J]. Adv Drug Deliv Rev, 2008,60(6):673-691.
11. WACHER V J, WU C Y, BENET L Z. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy[J]. Mol Carcinog, 1995,13(3):129-134.